T1	condition 14 24	lymphedema
T2	intervention 29 53	axillary reverse mapping
T3	ethinicity 225 233	Egyptian
T4	No-of-participants 542 544	48
T5	control 620 633	control group
T6	intervention-participants 649 651	24
T7	control-participants 649 651	24
T8	duration 906 914	6â€‰months
T9	outcome-Measure 924 947	incidence of lymphedema
T10	outcome 1274 1298	Lymph-node visualization
T11	intervention-value 1315 1317	20
T12	intervention-value 1332 1337	83.3%
T13	outcome 1359 1389	Suspicious stained lymph nodes
T14	intervention-value 1477 1479	20
T15	outcome 1512 1547	no stained lymph nodes were removed
T16	outcome 1553 1576	incidence of lymphedema
T17	control-value 1602 1607	16.7%
T18	intervention-value 1650 1654	4.2%
